373 related articles for article (PubMed ID: 30341577)
1. Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
Levin G; Rottenstreich A
Hormones (Athens); 2019 Jun; 18(2):137-139. PubMed ID: 30341577
[TBL] [Abstract][Full Text] [Related]
2. Long-term management of prolactinomas--use of long-acting dopamine agonists.
Cook DM
Rev Endocr Metab Disord; 2005 Jan; 6(1):15-21. PubMed ID: 15711910
[No Abstract] [Full Text] [Related]
3. Management of prolactinomas during pregnancy.
Witek P; Zieliński G
Minerva Endocrinol; 2013 Dec; 38(4):351-63. PubMed ID: 24285103
[TBL] [Abstract][Full Text] [Related]
4. Update on prolactinomas. Part 2: Treatment and management strategies.
Wong A; Eloy JA; Couldwell WT; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
[TBL] [Abstract][Full Text] [Related]
5. Prolactinomas and pregnancy.
Molitch ME
Clin Endocrinol (Oxf); 2010 Aug; 73(2):147-8. PubMed ID: 20550542
[No Abstract] [Full Text] [Related]
6. Giant macroprolactinoma and pregnancy.
Saraiva J; Gomes L; Paiva S; Ruas L; Carvalheiro M
Arq Bras Endocrinol Metabol; 2013 Oct; 57(7):558-61. PubMed ID: 24232822
[TBL] [Abstract][Full Text] [Related]
7. [Risk of prolactinoma growth during pregnancy. Visual field tests required in macroadenoma, small risk in microadenomas].
Ericsson C; Lindblom B
Lakartidningen; 2012 Jun 19-26; 109(25):1226-8. PubMed ID: 22838112
[No Abstract] [Full Text] [Related]
8. High prolactin level.
Piketty ML; Nataf F; Dilouya A; Roux FX
J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
[No Abstract] [Full Text] [Related]
9. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
Hamilton DK; Vance ML; Boulos PT; Laws ER
Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069
[TBL] [Abstract][Full Text] [Related]
10. Prolactinoma and pregnancy: From the wish of conception to lactation.
Maiter D
Ann Endocrinol (Paris); 2016 Jun; 77(2):128-34. PubMed ID: 27130071
[TBL] [Abstract][Full Text] [Related]
11. [Prolactin--a hormone with many effects].
Werner S; Bengtsson BA; Petruson B; Karlsson A; Bolander H; Bramnert M; Valdemarsson S; Bynke O; Ohman P; Olsson T; Rasmuson T; Anggård A
Lakartidningen; 1999 Mar; 96(10):1171-4. PubMed ID: 10193120
[No Abstract] [Full Text] [Related]
12. High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.
Banerjee A; Wynne K; Tan T; Hatfield EC; Martin NM; Williamson C; Meeran K
Clin Endocrinol (Oxf); 2009 May; 70(5):812-3. PubMed ID: 18803677
[No Abstract] [Full Text] [Related]
13. [Management of prolactinomas during pregnancy].
Chen W; Bian X; Gai M; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):335-7. PubMed ID: 12126566
[TBL] [Abstract][Full Text] [Related]
14. Cabergoline treatment of pregnant women with macroprolactinomas.
Laloi-Michelin M; Ciraru-Vigneron N; Meas T
Int J Gynaecol Obstet; 2007 Oct; 99(1):61-2. PubMed ID: 17602689
[No Abstract] [Full Text] [Related]
15. Medical management of prolactin-secreting pituitary adenomas.
Molitch ME
Pituitary; 2002; 5(2):55-65. PubMed ID: 12675502
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients.
Primeau V; Raftopoulos C; Maiter D
Eur J Endocrinol; 2012 May; 166(5):779-86. PubMed ID: 22301915
[TBL] [Abstract][Full Text] [Related]
17. Prolactinoma and pregnancy - a series of cases including pituitary apoplexy.
Galvão A; Gonçalves D; Moreira M; Inocêncio G; Silva C; Braga J
J Obstet Gynaecol; 2017 Apr; 37(3):284-287. PubMed ID: 27866462
[TBL] [Abstract][Full Text] [Related]
18. Management of psychosis associated with a prolactinoma: case report and review of the literature.
Ali S; Miller KK; Freudenreich O
Psychosomatics; 2010; 51(5):370-6. PubMed ID: 20833935
[TBL] [Abstract][Full Text] [Related]
19. [Update on endocrinology: management of prolactinomas during pregnancy].
Cecenarro LA; Estario P; Estario ME; Fux-Otta C
Rev Fac Cien Med Univ Nac Cordoba; 2015; 72(3):170-4. PubMed ID: 26913801
[TBL] [Abstract][Full Text] [Related]
20. PRL as a novel potent cofactor for platelet aggregation.
Wallaschofski H; Donné M; Eigenthaler M; Hentschel B; Faber R; Stepan H; Koksch M; Lohmann T
J Clin Endocrinol Metab; 2001 Dec; 86(12):5912-9. PubMed ID: 11739463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
